Friday 6 November 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue: +10.3%
EPS: +2,270.0%
Free cash flow: +9.97%
Total debt: +17.7%

Quarter to September 2026, against a year earlier

288.74 6.09 −2.07%

Follow ABBV

Alert me

Market cap: $509.5B
P/E: 49.7×
Fwd P/E: 38.6×
Dividend yield: 2.40%
F-score: 8/9
Altman Z: 2.31
Beneish M: −2.86
Dividend safety: 44/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

AbbVie Inc. (ABBV) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, AbbVie Inc. (ABBV) trades at a P/S ratio of 7.7×. Over the past ten years it has ranged from 2.9× (August 2019) to 7.9× (October 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 3.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABBV/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AbbVie Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABBV/metrics/ps-ratio">AbbVie Inc. (ABBV) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	6.6×	18.44%
FY2024	5.6×	7.27%
FY2023	5.2×	5.01%
FY2022	5.0×	16.16%
FY2021	4.3×	9.36%
FY2020	3.9×	(1.07%)
FY2019	3.9×	(9.12%)
FY2018	4.3×	(22.08%)
FY2017	5.6×	40.98%
FY2016	3.9×	(6.24%)

Period	P/S ratio	Change
Sep 2026	7.0×	1.39%
Jun 2026	6.9×	12.82%
Mar 2026	6.1×	(7.28%)
Dec 2025	6.6×	(3.76%)
43 more quarters	Free account

Against its own ten years

Low 2.9× High 7.9×

Ten-year median 4.5×

Current reading's percentile 100

Company	P/S ratio
PFE Pfizer Inc. compare	2.7×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG compare	5.4×
MRK Merck & Co., Inc. compare	5.4×
AMGN Amgen Inc. compare	6.4×
JNJ Johnson & Johnson compare	6.6×
GILD Gilead Sciences, Inc. compare	6.7×
ABBV AbbVie Inc.	7.7×
LLY Eli Lilly and Company compare	14.1×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

AbbVie Inc. (ABBV) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ABBV

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ABBV

Stockrow Weekly